INTELLECTUAL PROPERTY

The MIDS technology platform, used by us under a free licence from our founder shareholder, is protected by numerous patent applications now in the national phase in key geographic areas and already granted in China (grants in other territories almost certain to follow shortly). The Intellectual Property is 100% owned by our founding shareholder and licensed to MIDS Cardiac™.

  • PCT application number PCT/GB2011/050749
  • EP application number 11724436.8
  • USA application number 13809367 (Granted)
  • China application number 201180025701.5 (Granted)
  • India application number 9624/CHENP/2012

Sensitive, widely available detection  in emergencies

While other devices are limited to imperfect optical detection, NanoTesla Dx detects magnetically to a whole new level of accuracy.

Sensitive, widely available detection  in emergencies

While other devices are limited to imperfect optical detection, NanoTesla Dx detects magnetically to a whole new level of accuracy.

CONTACT US

NanoTesla Dx world class team is developing POC hand held devices using a next-generation nano magnetic medical diagnostic technology.

Address

© 2023 NanoTesla Dx. All rights reserved.